Professional Experience
Dr. Graser has accumulated significant experience in both clinical urology and oncologic research settings.
- 2018–2024: Senior Consultant in the Department of Urology, University Hospital Munich
- From 2018 onward: Participated in interventional and oncologic urology at Munich University Hospital
- Since joining ERC Munich: Brings urologic expertise in multidisciplinary tumor treatments
- Deputy principal investigator in renal cell carcinoma clinical trials (Roche, BMS, Eisai)
- Conducted laboratory research on immunotherapy in renal cell carcinoma collaborating with Institute of Immunology, Halle
Academic Contributions
Dr. Graser is active in scientific discourse, education, and oncology urology research.
- Over 40 scientific publications to her name
- Author of recent works such as “Dose‑escalated radiotherapy for clinically localized and locally advanced prostate cancer”
- Delivered lectures and seminars on urooncology, tumor therapy, and bladder cancer management
- Research interests include prostate cancer radiotherapy, kidney tumor immunotherapy, bladder cancer recurrence, and gender‑specific tumor outcomes
Areas of Expertise
Dr. Graser treats a broad range of urological tumors using state‑of‑the‑art techniques and interdisciplinary methods.
- Prostate cancer — diagnosis, radiotherapy dose escalation, surgical and radiosurgical approaches
- Kidney (renal) tumors — partial and radical nephrectomy, immunotherapy, radiosurgery integration
- Bladder cancer — non‑muscle invasive and muscle‑invasive bladder cancers, intravesical therapy strategies
- Upper urinary tract urothelial carcinomas (ureter, renal pelvis)
- Integration of urologic surgery and radiosurgical treatments in tumor care
Publications and Research
Dr. Graser has contributed to numerous high-impact studies in urooncology. Some notable publications include:
- “Dose‑escalated radiotherapy for clinically localized and locally advanced prostate cancer” — exploring higher-dose radiotherapy regimens in prostate cancer
- “Perioperative Outcomes After Radical Nephrectomy with Inferior Vena Cava Thrombectomy” — evaluating surgical outcomes in complex renal cancers
- “Sex‑specific differences in recurrence and progression following cytostatic intravesical chemotherapy for NMIBC” — analyzing gender differences in bladder cancer treatment outcomes
- “Gender‑Specific Differences in Recurrence following BCG Instillation for NMIBC” — investigating treatment response differences by sex
- “Image‑Guided Robotic Radiosurgery for Treatment of Lung Metastases of Renal Cell Carcinoma” — collaboration involving radiosurgical approaches in metastatic renal cancer
Patient Care Philosophy
Dr. Graser is committed to combining scientific excellence with empathetic, patient-focused care.
- Believes in individually tailored therapy balancing efficacy and quality of life
- Stresses clear and transparent patient communication about risks, benefits, and alternatives
- Supports interdisciplinary decision-making and collaboration with radiosurgeons and oncologists
- Offers online consultations and coordination for international patients
- Puts particular emphasis on patient education, follow-up, and satisfaction
Professional Affiliations
- Deutsche Gesellschaft für Urologie (DGU)
- European Association of Urology (EAU)
- German Society of Residents in Urology (GeSRU)
- UroEvidence (Review Board of the DGU)
FAQs
- Is Dr. med. Annabel Graser board‑certified?
- Yes, she is a recognized specialist in urology with additional certification in tumor therapy (medikamentöse Tumortherapie).
- What urologic tumor types does she treat?
- She treats prostate cancer, kidney (renal) tumors, bladder cancer (non‑muscle and muscle invasive), and upper urinary tract urothelial tumors.
- Does she treat international patients?
- Yes. As part of ERC Munich’s team, Dr. Graser participates in care for international patients, offering remote consultation and coordination support.
- How long is the typical hospital stay?
- The length of hospital stay depends on the procedure (surgery, radiotherapy, combined therapy). Some treatments may require multiple days; others may be outpatient when possible.
- What languages does she speak?
- Dr. Graser is fluent in German and English. The ERC Munich team supports multilingual communication for international patients.
- Can I request a remote consultation?
- Yes. ERC Munich provides online consultations to review medical records, imaging, and discuss treatment options before travel.
